MedPath

Montmorency Cherry Supplementation, Sleep, and Inflammation

Phase 1
Active, not recruiting
Conditions
Insomnia Chronic
Inflammation
Interventions
Dietary Supplement: Control
Dietary Supplement: Montmorency cherry supplement
Registration Number
NCT05700643
Lead Sponsor
Michigan State University
Brief Summary

This study will test the effects of Montmorency cherry supplementation on sleep outcomes and inflammatory biomarkers.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
64
Inclusion Criteria
  • body mass index (BMI) of ≥ 25.0 kg/m2;
  • sleep issues as identified by a global score of 5 or greater on the Pittsburgh Sleep Quality Index (PSQI) and/or a score 8 or higher on the Insomnia Severity Index (ISI);
  • ability to adhere to a diet low in antioxidants during the study period; and
  • willingness to wear a Fitbit for the duration of the study and to wear the Zmachine on selected nights.
Exclusion Criteria
  • unwilling or unable to stop the use of sleep medication
  • unable to attend laboratory visits on the East Lansing, Michigan campus

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
ControlControlPlacebo
InterventionMontmorency cherry supplement500 mg cherry supplement
Primary Outcome Measures
NameTimeMethod
Change in insomnia symptomsThrough study completion, two weeks for each arm

Insomnia Severity Index scores, scores range from 0-28, higher scores indicate worse outcomes

Change in total sleep timeThrough study completion, two weeks for each arm

sleep duration in hours and minutes

Change in sleep qualityThrough study completion, two weeks for each arm

Pittsburgh Sleep Quality Index scores, scores range from 0-21, higher scores indicate worse outcomes

Secondary Outcome Measures
NameTimeMethod
Change in Interleukin-8Through study completion, two weeks for each arm

blood work

Change in Interleukin-17Through study completion, two weeks for each arm

blood work

Change in Tumor necrosis factor-alphaThrough study completion, two weeks for each arm

blood work

Change in Interleukin-6Through study completion, two weeks for each arm

blood work

Change in C-reactive proteinThrough study completion, two weeks for each arm

blood work

Change in AnthropometricsThrough study completion, two weeks for each arm

Percent body fat

Trial Locations

Locations (1)

Michigan State University

🇺🇸

East Lansing, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath